^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

indatuximab ravtansine (BT-062)

i
Associations
Trials
Company:
Grifols
Drug class:
Microtubule inhibitor, CD138-targeted antibody-drug conjugate
Related drugs:
Associations
Trials